SCHEMBL7203314

SCHEMBL7203314

CS(=O)(=O)OCC#CC1CCC(NCC(=O)c2ccc(Cl)cc2)CC1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 1/20 0.37
FEN1 P39748 1/20 0.37
DPP4 P27487 1/20 0.36
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KCNH2 Q12809 1/20 0.34
MAPT P10636 3/20 0.34
L3MBTL1 Q9Y468 4/20 0.33
LMNA P02545 3/20 0.33
KMT2A Q03164 1/20 0.33
GAA P10253 1/20 0.33
TP53 P04637 1/20 0.33
LSS P48449 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HTT P42858 1/20 0.33
ATF4 P18848 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7203316 0.78 LSS (0.45) ALDH1A1SMN1; SMN2MAPTL3MBTL1LMNA
SCHEMBL7202897 0.74 LSS (0.45) DPP4KDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL27579928 0.72 LSS (0.62) SMN1; SMN2KCNH2MAPTL3MBTL1LMNA
SCHEMBL1484789 0.72 KDM4E (0.34) KDM4EALDH1A1LMNA
SCHEMBL6450860 0.72 GAA (0.41) ALDH1A1LMNAKMT2AGAALSS
SCHEMBL6019234 0.71 LSS (0.46) SMN1; SMN2KCNH2MAPTL3MBTL1LMNA
SCHEMBL6019239 0.71 LSS (0.46) SMN1; SMN2KCNH2MAPTL3MBTL1LMNA
SCHEMBL6450196 0.68 MGLL (0.47) ALDH1A1SMN1; SMN2MAPTLMNAKMT2A
SCHEMBL2544201 0.67 GSK3B (0.50) ERCC5FEN1KDM4EALDH1A1MAPT
SCHEMBL3867134 0.64 MEN1 (0.59) ERCC5FEN1KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1311475-A1 NOVEL AMINOCYCLOHEXANE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2003-05-21 EP disclosed
WO-2002014267-A1 NOVEL AMINOCYCLOHEXANE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-02-21 WO disclosed